Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Co-trimoxazole |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Co-trimoxazole |
Inferred relationship |
Some |
|
forgiftning med co-trimoxazol |
Causative agent |
False |
Co-trimoxazole |
Inferred relationship |
Some |
|
accidentel forgiftning med co-trimoxazol |
Causative agent |
False |
Co-trimoxazole |
Inferred relationship |
Some |
|
tilsigtet forgiftning med co-trimoxazol |
Causative agent |
False |
Co-trimoxazole |
Inferred relationship |
Some |
|
forgiftning med co-trimoxazol, uvist med hvilken hensigt |
Causative agent |
False |
Co-trimoxazole |
Inferred relationship |
Some |
|
bivirkning af co-trimoxazol |
Causative agent |
False |
Co-trimoxazole |
Inferred relationship |
Some |
|
allergi over for sulfamethoxazol og trimethoprim |
Causative agent |
False |
Co-trimoxazole |
Inferred relationship |
Some |
|
overdosis af co-trimoxazol |
Causative agent |
False |
Co-trimoxazole |
Inferred relationship |
Some |
|
accidentel overdosis af co-trimoxazol |
Causative agent |
False |
Co-trimoxazole |
Inferred relationship |
Some |
|
tilsigtet overdosis af co-trimoxazol |
Causative agent |
False |
Co-trimoxazole |
Inferred relationship |
Some |
|
overdosis af co-trimoxazol, uvist med hvilken hensigt |
Causative agent |
False |
Co-trimoxazole |
Inferred relationship |
Some |
|
Co-trimoxazole [generic] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Co-trimoxazole |
Inferred relationship |
Some |
|
Product containing precisely sulfamethoxazole 400 milligram and trimethoprim 80 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Co-trimoxazole |
Inferred relationship |
Some |
|
co-trimoxazol 80 mg/400 mg dispergibel tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Co-trimoxazole |
Inferred relationship |
Some |
|
Sulfamethoxazole 800 mg and trimethoprim 160 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Co-trimoxazole |
Inferred relationship |
Some |
|
co-trimoxazol 160 mg/800 mg dispergibel tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Co-trimoxazole |
Inferred relationship |
Some |
|
co-trimoxazol 40 mg/80 mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Co-trimoxazole |
Inferred relationship |
Some |
|
Sulfamethoxazole 80 mg/mL and trimethoprim 16 mg/mL oral suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Co-trimoxazole |
Inferred relationship |
Some |
|
co-trimoxazol 40 mg/200 mg/5 ml suspension til børn |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Co-trimoxazole |
Inferred relationship |
Some |
|
co-trimoxazol 16 mg/80 mg/ml koncentrat til infusionsvæske, ampul a 5 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Co-trimoxazole |
Inferred relationship |
Some |
|
co-trimoxazol 40 mg/200 mg/5 ml sukkerfri suspension til børn |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Co-trimoxazole |
Inferred relationship |
Some |
|
Co-trimoxazole [proprietary] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Co-trimoxazole |
Inferred relationship |
Some |
|
Product containing sulfamethoxazole and trimethoprim in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Co-trimoxazole |
Inferred relationship |
Some |
|
Sulfamethoxazole- and trimethoprim-containing product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Co-trimoxazole |
Inferred relationship |
Some |
|
co-trimoxazol 16 mg/80 mg/ml infusionsvæske, opløsning, ampul a 20 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Co-trimoxazole |
Inferred relationship |
Some |
|
Co-trimoxazole 16mg/80mg/mL infusion solution 10mL ampule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Co-trimoxazole |
Inferred relationship |
Some |
|
co-trimoxazol 960 mg/10 ml infusionsvæske til intravenøs anvendelse |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Co-trimoxazole |
Inferred relationship |
Some |
|